Plans have been submitted to install a phone mast in a small village south of Shrewsbury. Atlas Tower Group has submitted ...
Live webcasts of the presentations will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...
Caroline Quinn, 25, has shared how suffering from mast cell activation syndrome (MCAS) has affected many aspects of her life ...
JPMorgan initiated coverage of Blueprint Medicines (BPMC) with an Overweight rating and $126 price target Blueprint is a biotech company ...
Atlas Tower Group has submitted plans for a 24/7 telecommunications cell site to be place on land at Frodesley Hall Farm in ...
Caroline Quinn, 25, from Boston, MA, faces unique challenges in love due to a rare immune disease and severe allergies. With ...
The National Institute for Health and Care Excellence (NICE) has recommended Blueprint Medicines’ Ayvakyt (avapritinib) to ...
An estimated 1 to 3 million people suffer from POTS. In addition to POTS, Knowles struggles with Sjögren’s syndrome and mast ...
HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: Guggenheim ...
Credit: SWNS / Caroline Cray A woman who is "allergic to everything" can only eat oatmeal and says fish, nuts or mustard could prove deadly. Caroline Cray, 24, first realised something was wrong when ...
Jasper Therapeutics ( JSPR, Financial) has been on analysts' radar lately. JMP Securities analyst Silvan Tuerkcan gave the stock a "buy" rating and projected it to reach $70.00. The Tuerkcan's ...